A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer
Clinical trial NCT05241899 · UNKNOWN
Trial details
- NCT number
- NCT05241899
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-07
- Primary completion
- 2023-05-07
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.